## FFIV: F5, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_20 3.4% below STRENGTH zone (4.0-10.0%); PEG 2.04 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($246.66)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 10)

**1. F5 ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against F5, Inc. and Encourages Investors to Contact the Firm**
- Source: GlobeNewswire | 20251223T004827 | Bearish | Relevance: 100%
- Bragar Eagel & Squire, P.C. has announced the filing of a class action lawsuit against F5, Inc. (NASDAQ: FFIV) on behalf of investors who purchased securities between October 28, 2024, and October 27, 2025. The lawsuit alleges that F5 made misleading statements and concealed a significant security breach that impacted its data security capabilities and future growth projections. Investors are encouraged to contact the law firm to discuss their legal rights.

**2. FFIV ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of F5, Inc. Investors**
- Source: Business Wire | 20251222T230927 | Bearish | Relevance: 100%
- Kirby McInerney LLP has filed a securities class action lawsuit against F5, Inc. (NASDAQ:FFIV) on behalf of investors who purchased securities between October 28, 2024, and October 27, 2025. The lawsuit alleges F5 made misleading statements about its cybersecurity capabilities while experiencing a significant security breach, which led to a substantial decline in its stock price. Investors who suffered losses have until February 17, 2026, to request lead plaintiff appointment.

**3. F5, INC. (NASDAQ: FFIV) INVESTOR ALERT Investors With Large**
- Source: GlobeNewswire | 20251222T214928 | Bearish | Relevance: 100%
- Bernstein Liebhard LLP has announced a securities class action lawsuit against F5, Inc. (NASDAQ: FFIV) on behalf of investors who purchased shares between October 28, 2024, and October 27, 2025. The lawsuit alleges that F5 made misrepresentations regarding its security capabilities. Investors with significant losses are encouraged to contact the firm to discuss their rights and the possibility of serving as a lead plaintiff by February 17, 2026.

**4. Investor Notice: Robbins LLP Informs Investors of F5, Inc. Securities Class Action**
- Source: Business Wire | 20251222T210631 | Bearish | Relevance: 100%
- Robbins LLP has filed a class action lawsuit against F5, Inc. (NASDAQ: FFIV) on behalf of investors who purchased securities between October 28, 2024, and October 27, 2025. The lawsuit alleges that F5, Inc. misled investors about the financial impact of a significant security breach that compromised its BIG-IP product development platforms and source code. This breach led to a substantial decline in F5's stock price following announcements regarding the breach and subsequent reduced growth expectations for fiscal year 2026.

**5. FFIV Investors Have Opportunity to Lead F5, Inc. Securities Fraud Lawsuit with the Schall Law Firm**
- Source: The AI Journal | 20251222T194840 | Bearish | Relevance: 100%
- The Schall Law Firm is reminding investors of a class action lawsuit against F5, Inc. (NASDAQ: FFIV) for alleged securities fraud. The lawsuit claims F5 made false and misleading statements regarding its security and customer fulfillment capabilities, despite suffering a security incident that jeopardized customer data and growth prospects. Investors who purchased F5 securities between October 28, 2024, and October 27, 2025, are encouraged to contact the firm before February 17, 2026, to discuss their rights.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $296 | $336 | -12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 13 ($0.00M) |
| Sells | 18 ($3.55M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 51.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (-2.1%)
- Blackrock Inc.: 11.0% (-1.9%)
- Hotchkis & Wiley Cap: 8.3% (-7.5%)
- State Street Corpora: 5.5% (+1.7%)
- Geode Capital Manage: 3.0% (+1.7%)

### Key Risks

1. Insider selling cluster: $3.5M in recent transactions.
2. Long-term trend broken: trading 8.8% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.04 elevated, pricing in significant growth expectations. Forward P/E 16.1x stretched relative to 8% growth. Quality metrics strong (ROE 21%, margin 22%). Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($3.5M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $15.1B |
| Beta | 0.99 |
| 52W Range | $223.76 - $346.00 |
| Short Interest | 7.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.04 |
| Forward P/E | 16.1 |
| Current P/E | 17.3 |
| YoY Growth | 7.8% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 5.9% to 3.4% (-2.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 0.6pp (needs >4.0% for momentum thesis). MRS_5 (-0.5%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 4.0% shows strong absolute momentum above own 20MA. Outperforming sector by 3.2pp, stock-specific strength. Below SMA200 (0.91x), long-term trend not supportive. MACD histogram positive (2.24), confirming momentum. RSI neutral at 57. OFD pattern: +MUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.39% (CS: 75) | Neutral |
| RSI_14 | 57.1 | Neutral |
| MACD Histogram | 2.24 | Bullish |
| vs SMA20 | 1.040x | Above |
| vs SMA50 | 1.001x | Above |
| vs SMA200 | 0.912x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $260.40
- **Stop Loss:** $246.66 (5.3% risk)
- **Target:** $274.14 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 87
- **Position Value:** $22,654.80
- **Portfolio %:** 22.65%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-01-27 (Est: $3.64)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.97 | $4.39 | +10.6% |
| 2025Q2 | $3.49 | $4.16 | +19.2% |
| 2025Q1 | $3.09 | $3.42 | +10.5% |
| 2024Q4 | $3.38 | $3.84 | +13.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*